PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-10-20

Date Title Company
20-Oct-2022 After the first nine months, the Zur Rose Group is at the upper end of targets for revenue and EBITDA for 2022 Zur Rose Group AG
20-Oct-2022 Cosmo announces FDA grants orphan-drug designation of rifamycin for treatment of pouchitis Cosmo Pharmaceuticals N.V.